NEWTON, Mass., October 15, 2025--(BUSINESS WIRE)--ClearB Therapeutics, Inc., a clinical-stage biotechnology company committed to developing therapies to drive functional cure in patients with chronic ...
The share price of Core Laboratories Inc. (NYSE:CLB) fell by 1.61% between July 22 and July 29, 2025, putting it among the Energy Stocks that Lost the Most This Week. A drilling rig manned by ...
Hosted on MSN
Core Laboratories Inc. (CLB) gains on sequential revenue growth and Solintec acquisition
Ariel Investments, an investment management company, released its “Ariel Fund” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund delivered a +3.22% return in ...
View Core Laboratories Inc. CLB stock quote prices, financial information, real-time forecasts, and company news from CNN.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results